Reaction
Genital Rash reporting signals
As of the last recalculation, Genital Rash appears in 1,402 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is ABACAVIR SULFATE (PRR 26.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Abacavir Sulfate | 17 | 26.2 | 26.3 |
| Cabozantinib | 75 | 24.4 | 24.5 |
| Miconazole Nitrate | 14 | 24.0 | 24.1 |
| Nevirapine | 13 | 21.6 | 21.6 |
| Canagliflozin | 31 | 15.7 | 15.7 |
| Carboxymethylcellulose Sodium | 9 | 14.3 | 14.3 |
| Drs. Clotrimazole | 11 | 14.2 | 14.2 |
| Family Wellness Clotrimazole | 11 | 14.2 | 14.2 |
| Clotrimazole Topical | 11 | 14.2 | 14.2 |
| Clotrimazole | 11 | 13.4 | 13.4 |
| Empagliflozin | 57 | 13.1 | 13.1 |
| Sorafenib | 18 | 13.0 | 13.0 |
| Fexofenadine | 12 | 10.9 | 10.9 |
| Sunitinib Malate | 26 | 10.0 | 10.0 |
| Chlorthalidone | 7 | 9.0 | 9.0 |
| Axitinib | 11 | 8.4 | 8.4 |
| Lamivudine | 17 | 8.3 | 8.3 |
| Peginterferon Alfa-2A | 27 | 7.5 | 7.5 |
| Etonogestrel And Ethinyl Estradiol | 11 | 7.4 | 7.4 |
| Regorafenib | 5 | 6.4 | 6.4 |
| Panitumumab | 6 | 5.7 | 5.7 |
| Apalutamide | 4 | 5.1 | 5.1 |
| Tafamidis | 3 | 3.8 | 3.8 |
| Levonorgestrel | 32 | 2.4 | 2.4 |
| Nirmatrelvir And Ritonavir | 7 | 1.9 | 1.9 |